Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism are dependent on the time for which the International Normalized Ratio (INR) is in the therapeutic range. The objective of our study was to determine the effect of introducing a simple two-step dosing algorithm, as compared with dosing by anticoagulation clinic staffs on the basis of their experience, on time in therapeutic range (TTR) of warfarin therapy. Methods: We compared TTRs of all clinic patients before and after the introduction of a simple two-step dosing algorithm at a single anticoagulation clinic in Canada, between 1 August 2006 and 24 December 2008. TTR was calculated using the linear interpolation method of Rosendaal. Results: W...
Background. Warfarin is the most commonly used anticoagulant for both primary and secondary preventi...
International audienceINTRODUCTION: Despite the increasing utilization of direct oral anticoagulant ...
Introduction: Warfarin treatment with a high time in therapeutic range (TTR) is correlated to fewer ...
Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism a...
Background: In the ROCKET AF (Rivaroxaban–Once‐daily, oral, direct Factor Xa inhibition Compared wit...
Aim. To compare two approaches to warfarin dosage formulation: the standard and with the clinical al...
International audience: In many countries, new oral anticoagulants are only covered for patients wit...
International audiencePatients on warfarin with sub-optimal time-in-therapeutic-range (TTR) are more...
Background: Well-managed warfarin treatment with a high time in therapeutic range (TTR) corresponds ...
OBJECTIVE: The purpose of this study was to analyze the difference in duration of anticoagulation an...
Good anticoagulation control in patients during the first months after heart valve surgery is import...
Background: The potential for medication errors in a hospital setting has led to a change from daily...
Objective: to evaluate the influence of structurized dosing of warfarin in patients with permanent a...
Objective: Anticoagulation management with warfarin is a familiar challenge seen in primary care set...
Background. Warfarin is the most commonly used anticoagulant for both primary and secondary preventi...
Background. Warfarin is the most commonly used anticoagulant for both primary and secondary preventi...
International audienceINTRODUCTION: Despite the increasing utilization of direct oral anticoagulant ...
Introduction: Warfarin treatment with a high time in therapeutic range (TTR) is correlated to fewer ...
Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism a...
Background: In the ROCKET AF (Rivaroxaban–Once‐daily, oral, direct Factor Xa inhibition Compared wit...
Aim. To compare two approaches to warfarin dosage formulation: the standard and with the clinical al...
International audience: In many countries, new oral anticoagulants are only covered for patients wit...
International audiencePatients on warfarin with sub-optimal time-in-therapeutic-range (TTR) are more...
Background: Well-managed warfarin treatment with a high time in therapeutic range (TTR) corresponds ...
OBJECTIVE: The purpose of this study was to analyze the difference in duration of anticoagulation an...
Good anticoagulation control in patients during the first months after heart valve surgery is import...
Background: The potential for medication errors in a hospital setting has led to a change from daily...
Objective: to evaluate the influence of structurized dosing of warfarin in patients with permanent a...
Objective: Anticoagulation management with warfarin is a familiar challenge seen in primary care set...
Background. Warfarin is the most commonly used anticoagulant for both primary and secondary preventi...
Background. Warfarin is the most commonly used anticoagulant for both primary and secondary preventi...
International audienceINTRODUCTION: Despite the increasing utilization of direct oral anticoagulant ...
Introduction: Warfarin treatment with a high time in therapeutic range (TTR) is correlated to fewer ...